2022
DOI: 10.1016/j.bios.2022.114619
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal network-based biomimetic chip for long-term detection of olfactory dysfunction model in early-stage Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…[123] Aš›½ oligomer-induced AD chips can also be used for spatial firing pattern mapping and cross-correlation between channels to verify the degradation mechanism of neural network connections. [124] Additionally, reported AD models based on the microfluidic chip were used to understand abnormal protein transport characterization, [125] and analyze the local mechanism of Aš›½-induced neurotoxicity in neurons, [126] early AD olfactory dysfunction, [127] and the responsive movement of microglia to different types of Aš›½. [128] The BBB/neurovascular unit chip also contributes more possibilities in AD research, such as revealing the causal effect between the increase in BBB permeability and the pathogenesis of AD [129,130] and screening new drugs for AD.…”
Section: Neurodegenerative Diseasementioning
confidence: 99%
“…[123] Aš›½ oligomer-induced AD chips can also be used for spatial firing pattern mapping and cross-correlation between channels to verify the degradation mechanism of neural network connections. [124] Additionally, reported AD models based on the microfluidic chip were used to understand abnormal protein transport characterization, [125] and analyze the local mechanism of Aš›½-induced neurotoxicity in neurons, [126] early AD olfactory dysfunction, [127] and the responsive movement of microglia to different types of Aš›½. [128] The BBB/neurovascular unit chip also contributes more possibilities in AD research, such as revealing the causal effect between the increase in BBB permeability and the pathogenesis of AD [129,130] and screening new drugs for AD.…”
Section: Neurodegenerative Diseasementioning
confidence: 99%